Exponent (NASDAQ:EXPO - Get Free Report) is projected to announce its Q2 2025 earnings results after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $0.48 per share and revenue of $130.82 million for the quarter.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to the consensus estimate of $134.63 million. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The business's quarterly revenue was up .2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.59 EPS. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Stock Down 2.1%
Shares of NASDAQ EXPO traded down $1.55 during trading on Friday, reaching $72.51. 258,694 shares of the company traded hands, compared to its average volume of 263,988. The firm has a 50 day simple moving average of $76.26 and a 200-day simple moving average of $81.51. Exponent has a 52-week low of $71.72 and a 52-week high of $115.75. The stock has a market capitalization of $3.68 billion, a PE ratio of 35.37 and a beta of 0.90.
Exponent Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Friday, June 6th. Exponent's dividend payout ratio (DPR) is presently 58.54%.
Insider Activity
In other Exponent news, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP John Pye sold 2,000 shares of the business's stock in a transaction on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total transaction of $152,640.00. Following the sale, the vice president directly owned 29,204 shares of the company's stock, valued at $2,228,849.28. This represents a 6.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,267 shares of company stock worth $489,120 over the last quarter. Insiders own 1.60% of the company's stock.
Institutional Trading of Exponent
An institutional investor recently bought a new position in Exponent stock. United Services Automobile Association bought a new position in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,282 shares of the business services provider's stock, valued at approximately $270,000. 92.37% of the stock is owned by institutional investors.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.